Skip to content

Sacrospinous ligament fixation versus Elevate Posterior procedure in treatment of primary prolapse.

Sacrospinous ligament fixation versus Elevate Posterior procedure in treatment of primary apical prolapse stage 2 or more: A multi-center randomised controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON27804
Enrollment
100
Registered
2011-09-19
Start date
2012-01-01
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic organ prolapse. Surgery. Mesh. Recurrence. Sexual function. Vaginale verzakking. Chirurgie. Mesh/implantaat. Recidief. Seksuele functie.

Interventions

Elevate Posterior or sacrospinous ligament fixation.

Sponsors

University Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Sexually active women with a primary apical compartment prolapse stage 2 or more requiring surgery. Patients with co-existing posterior defects or concomitant perineal surgery (perineoplasty) can be included.

Exclusion criteria

Exclusion criteria: 1. Previous prolapse surgery; 2. Enterocele stage 2 or more after hysterectomy (performed for other reasons than prolapse); 3. Known malignancy; 4. Pregnancy or wish to become pregnant; 5. Unwilling to return for follow-up or language barriers; 6. Presence of immunological / haematological disorders interfering with recovery after surgery; 7. Abnormal ultrasound findings of uterus or ovaries.

Design outcomes

Primary

MeasureTime frame
Sexual function at one year after intervention measured using the PISQ-12.

Secondary

MeasureTime frame
POP-Q, morbidity (including post-operative pain, complications and recovery of normal daily activities), disease specific and generic quality of life, repeated pelvic floor surgery within 12 months after intervention and cost analysis.

Contacts

Public ContactJan-Paul W.R. Roovers

PO Box 22660

j.p.roovers@amc.uva.nl+31 (0)20 5666429

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)